Blood News and Research

RSS

Sensyne collaborates with University of Oxford’s Big Data Institute to find solutions for chronic diseases

Sensyne Health plc. today announces a three-year collaboration with the University of Oxford to develop AI for chronic disease.

29 Jan 2019

Researchers compare treatment options for fecal incontinence

It is a common health problem that causes uncommon personal discomfort. Fecal incontinence, or accidental stool leakage, affects some 8 to 10 percent of the 325 million people in the United States. In up to half of patients, there is both fecal and urinary incontinence.

29 Jan 2019

Healthy men with high waist-stature ratio have increased risk of cardiovascular disease

Health experts have warned for years that men and women with excess abdominal fat run a greater risk of developing cardiovascular problems.

29 Jan 2019

New study elucidates role of signaling molecule in development of myocarditis

Researchers of Ludwig-Maximilians-Universitaet in Munich have shown that a protein called midkine, a member of the class of signaling molecules known as cytokines, is a key driver of inflammation in the heart muscle that can lead to heart failure in patients with myocarditis.

29 Jan 2019

Big data opens door for characterizing immunity-related genome in Japanese population

Although different genes are distributed widely across chromosomes, many genes related to the immune system are clustered together on human chromosome 6, in a segment called the major histocompatibility complex (MHC) region.

29 Jan 2019

Female stroke survivors twice as likely to suffer from severe depression

New research today published in the European Journal of Neurology has found that women are twice as likely to suffer from severe depression following a stroke than men.

29 Jan 2019

Fibrosis-targeting drugs may benefit patients with late-stage, metastatic breast cancer

A Massachusetts General Hospital (MGH) research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer.

29 Jan 2019

Stand Up To Cancer creates Dream Team focused on finding therapies for T-cell lymphoma

Stand Up To Cancer announced here today the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma, a rare cancer of the blood and immune system, using chimeric antigen receptors (CARs) to trigger the immune system to attack and destroy cancerous cells.

29 Jan 2019

New drug compounds show promise in treating acute myeloid leukemia

Researchers have been struggling for years to find a treatment for patients who have a recurrence of acute myeloid leukemia (AML), an aggressive blood cancer that is one of the most lethal cancers. About 19,520 news cases are diagnosed a year, and about 10,670 people a year die from it, according to the American Cancer Society.

29 Jan 2019

Satiety hormone could decrease a person's risk of developing Alzheimer's disease

You may be familiar with the saying, "You are what you eat," but did you know the food you eat could impact your memory?

29 Jan 2019

People with sight problems could benefit from new surgical trial

People with sight problems could benefit from a surgical trial advance that has been shown to help restore the surface of the eye.

29 Jan 2019

New approach identifies epigenetic changes in leukemia cells for patients undergoing ibrutinib treatment

Many new anti-cancer drugs inhibit proteins that are essential for the proliferation of cancer cells. One example is ibrutinib, an innovative therapy for chronic lymphocytic leukemia first approved in 2014.

29 Jan 2019

Alzheimer's Association grants more than $800,000 to support the SPRINT MIND Study

The Alzheimer's Association has awarded more than $800,000 to support the SPRINT MIND 2.0 Study, which will further investigate the impact of intensive blood pressure treatment on reducing risk of dementia.

29 Jan 2019

EU research project is studying the effect of endocrine disruptors on metabolism

January 2019 saw the launch of the EU research project EDCMET, in which scientists from the German Federal Institute for Risk Assessment (BfR) are also involved.

28 Jan 2019

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

28 Jan 2019

Blood News and Research

Sensyne collaborates with University of Oxford’s Big Data Institute to find solutions for chronic diseases

Researchers compare treatment options for fecal incontinence

Healthy men with high waist-stature ratio have increased risk of cardiovascular disease

New study elucidates role of signaling molecule in development of myocarditis

Big data opens door for characterizing immunity-related genome in Japanese population

Female stroke survivors twice as likely to suffer from severe depression

Fibrosis-targeting drugs may benefit patients with late-stage, metastatic breast cancer

Stand Up To Cancer creates Dream Team focused on finding therapies for T-cell lymphoma

New drug compounds show promise in treating acute myeloid leukemia

Satiety hormone could decrease a person's risk of developing Alzheimer's disease

People with sight problems could benefit from new surgical trial

New approach identifies epigenetic changes in leukemia cells for patients undergoing ibrutinib treatment

Alzheimer's Association grants more than $800,000 to support the SPRINT MIND Study

EU research project is studying the effect of endocrine disruptors on metabolism

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

Discovery reveals how to 'slim down' fat-carrying particles to reduce spread of 'bad' cholesterol

Scientists are working to develop a new way to detect Zika virus

Researchers develop new tool that images blood flow through tiny capillaries

UTHealth enrolls first U.S. patient in novel stem cell trial to treat stroke disability

Targeting Sirt-1 enzyme shows promise in controlling graft-vs-host disease

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News